ESR1 and in situ carcinoma: Elevated ESR1 expression has been observed in atypical ductal hyperplasia and in situ carcinoma, suggesting that deregulation of the ESR1 expression level may be implicated in early pathogenic changes during breast tumorigenesis [62,75].